The science
The biology of soft plaque, why standard tests miss it, and how modern imaging plus AI changes the equation entirely.
How often someone in the U.S. has a heart attack, according to the American Heart Association. For many, the first one arrives with no warning at all.
Heart attacks linked to soft, non-calcified plaque — the kind stress tests, EKGs, and calcium scores aren't designed to detect.
What many people recall being told at a recent checkup — because the standard tests weren't looking for soft plaque.
Heart disease is the #1 killer in America — and almost no one sees it coming. It doesn't have to be you.
What standard heart tests can't see
For decades, standard heart screenings — stress tests, EKGs, and even calcium scores — have lulled millions into a dangerous false sense of security. These tests can't see the real threat: they only detect blockages, the final stage of the disease, often after it's been silently growing for years.
But heart attacks rarely come from full blockages. Most begin when soft plaque — non-calcified, lipid-rich plaque buried inside the artery wall — ruptures without warning. A 640-slice cardiac CT angiogram (CCTA) with FDA-cleared AI analysis can detect and measure this plaque years before symptoms. The result of testing the wrong thing? People who "feel fine" and "pass every checkup" can still be carrying plaque that standard tests were never built to find.
This isn't prevention. It's reactive medicine, built to respond after the damage is done — while heart disease remains America's leading cause of death, even though its earliest stage is now visible and treatable.
A stress test only turns positive when an artery is roughly 70% blocked. Most heart attacks happen at plaques narrowing the artery far less than that — they rupture suddenly, forming a clot that blocks the vessel in minutes. That's why people pass a stress test and have an event weeks later: the test was answering a different question.
Calcium scoring only detects hardened, calcified plaque — the older, more stable kind. The soft, lipid-rich plaque that ruptures is invisible to it. A zero score is good news, but it is not a clean bill of health. Soft plaque hides inside the artery wall, where only CCTA can see it.
The scan captures the entire coronary tree in high definition. FDA-cleared AI then quantifies every plaque by volume, density, composition and location — to a tenth of a cubic millimeter. You get a precise map: how much plaque, what kind, where, and how fast it changes between scans.
With aggressive lipid management, blood-pressure control, and targeted lifestyle medicine, soft-plaque burden can be tracked over time and, with treatment, stabilized or reduced. Because your plaque is quantified, progress isn't a feeling — it's a number you can track scan over scan.
Book a call
Apply to become a ClearCardio patient at our Carrollton, TX practice — serving the entire Dallas–Fort Worth area. Our Patient Assessment Team will review your history, symptoms, risk factors and prior tests — and confirm if the program is right for you. Real answers in as little as 7 days.